Literature DB >> 19293778

Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.

Giulietta Maruggi1, Simona Porcellini, Giulia Facchini, Serena K Perna, Claudia Cattoglio, Daniela Sartori, Alessandro Ambrosi, Axel Schambach, Christopher Baum, Chiara Bonini, Chiara Bovolenta, Fulvio Mavilio, Alessandra Recchia.   

Abstract

The integration characteristics of retroviral (RV) vectors increase the probability of interfering with the regulation of cellular genes, and account for a tangible risk of insertional mutagenesis in treated patients. To assess the potential genotoxic risk of conventional or self-inactivating (SIN) gamma-RV and lentiviral (LV) vectors independently from the biological consequences of the insertion event, we developed a quantitative assay based on real-time reverse transcriptase--PCR on low-density arrays to evaluate alterations of gene expression in individual primary T-cell clones. We show that the Moloney leukemia virus long terminal repeat (LTR) enhancer has the strongest activity in both a gamma-RV and a LV vector context, while an internal cellular promoter induces deregulation of gene expression less frequently, at a shorter range and to a lower extent in both vector types. Downregulation of gene expression was observed only in the context of LV vectors. This study indicates that insertional gene activation is determined by the characteristics of the transcriptional regulatory elements carried by the vector, and is largely independent from the vector type or design.

Entities:  

Mesh:

Year:  2009        PMID: 19293778      PMCID: PMC2835143          DOI: 10.1038/mt.2009.51

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  22 in total

1.  Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.

Authors:  M Schmidt; G Hoffmann; M Wissler; N Lemke; A Müssig; H Glimm; D A Williams; S Ragg; C U Hesemann; C von Kalle
Journal:  Hum Gene Ther       Date:  2001-05-01       Impact factor: 5.695

2.  Murine leukemia induced by retroviral gene marking.

Authors:  Zhixiong Li; Jochen Düllmann; Bernd Schiedlmeier; Manfred Schmidt; Christof von Kalle; Johann Meyer; Martin Forster; Carol Stocking; Anke Wahlers; Oliver Frank; Wolfram Ostertag; Klaus Kühlcke; Hans-Georg Eckert; Boris Fehse; Christopher Baum
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

Review 3.  Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.

Authors:  Matthew P McCormack; Terence H Rabbitts
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

Review 4.  Genome-wide analysis of retroviral DNA integration.

Authors:  Frederic Bushman; Mary Lewinski; Angela Ciuffi; Stephen Barr; Jeremy Leipzig; Sridhar Hannenhalli; Christian Hoffmann
Journal:  Nat Rev Microbiol       Date:  2005-11       Impact factor: 60.633

5.  Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

Authors:  Olga Kustikova; Boris Fehse; Ute Modlich; Min Yang; Jochen Düllmann; Kenji Kamino; Nils von Neuhoff; Brigitte Schlegelberger; Zhixiong Li; Christopher Baum
Journal:  Science       Date:  2005-05-20       Impact factor: 47.728

6.  Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.

Authors:  Alessandra Recchia; Chiara Bonini; Zulma Magnani; Fabrizia Urbinati; Daniela Sartori; Sara Muraro; Enrico Tagliafico; Attilio Bondanza; Maria Teresa Lupo Stanghellini; Massimo Bernardi; Alessandra Pescarollo; Fabio Ciceri; Claudio Bordignon; Fulvio Mavilio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

7.  Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors.

Authors:  Francesca Di Nunzio; Giulietta Maruggi; Stefano Ferrari; Enzo Di Iorio; Valentina Poletti; Marta Garcia; Marcela Del Rio; Michele De Luca; Fernando Larcher; Graziella Pellegrini; Fulvio Mavilio
Journal:  Mol Ther       Date:  2008-09-23       Impact factor: 11.454

8.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

9.  Safety of retroviral gene marking with a truncated NGF receptor.

Authors:  C Bonini; M Grez; C Traversari; F Ciceri; S Marktel; G Ferrari; M Dinauer; M Sadat; A Aiuti; S Deola; M Radrizzani; A Hagenbeek; J Apperley; S Ebeling; A Martens; H J Kolb; M Weber; F Lotti; A Grande; E Weissinger; J A Bueren; M Lamana; J H F Falkenburg; M H M Heemskerk; T Austin; S Kornblau; F Marini; C Benati; Z Magnani; S Cazzaniga; S Toma; C Gallo-Stampino; M Introna; S Slavin; P D Greenberg; M Bregni; F Mavilio; C Bordignon
Journal:  Nat Med       Date:  2003-04       Impact factor: 53.440

10.  Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation.

Authors:  Sarah Marktel; Zulma Magnani; Fabio Ciceri; Sabrina Cazzaniga; Stanley R Riddell; Catia Traversari; Claudio Bordignon; Chiara Bonini
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

View more
  38 in total

1.  Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts.

Authors:  Arianna Moiani; Ylenia Paleari; Daniela Sartori; Riccardo Mezzadra; Annarita Miccio; Claudia Cattoglio; Fabienne Cocchiarella; Maria Rosa Lidonnici; Giuliana Ferrari; Fulvio Mavilio
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

2.  RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Authors:  Anna Stornaiuolo; Bianca Maria Piovani; Sergio Bossi; Eleonora Zucchelli; Stefano Corna; Francesca Salvatori; Fulvio Mavilio; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Hum Gene Ther Methods       Date:  2013-08-03       Impact factor: 2.396

3.  T lymphocytes are not immune.

Authors:  Gianpietro Dotti
Journal:  Mol Ther       Date:  2013-06       Impact factor: 11.454

4.  Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region.

Authors:  Paritha I Arumugam; Tomoyasu Higashimoto; Fabrizia Urbinati; Ute Modlich; Shawna Nestheide; Ping Xia; Catherine Fox; Andrea Corsinotti; Christopher Baum; Punam Malik
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

5.  Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

Authors:  Ute Modlich; Susana Navarro; Daniela Zychlinski; Tobias Maetzig; Sabine Knoess; Martijn H Brugman; Axel Schambach; Sabine Charrier; Anne Galy; Adrian J Thrasher; Juan Bueren; Christopher Baum
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

6.  Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.

Authors:  Sean Knight; Marieke Bokhoven; Mary Collins; Yasuhiro Takeuchi
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

7.  Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.

Authors:  Dirk Heckl; Adrian Schwarzer; Reinhard Haemmerle; Doris Steinemann; Cornelia Rudolph; Britta Skawran; Sabine Knoess; Johanna Krause; Zhixiong Li; Brigitte Schlegelberger; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

8.  SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.

Authors:  Matthias Titeux; Valérie Pendaries; Maria A Zanta-Boussif; Audrey Décha; Nathalie Pironon; Laure Tonasso; José E Mejia; Agnes Brice; Olivier Danos; Alain Hovnanian
Journal:  Mol Ther       Date:  2010-05-18       Impact factor: 11.454

9.  Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors.

Authors:  Joerg Enssle; Grant D Trobridge; Kirsten A Keyser; Christina Ironside; Brian C Beard; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

10.  Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.

Authors:  Maria Garcia-Gomez; Andrea Calabria; Maria Garcia-Bravo; Fabrizio Benedicenti; Penelope Kosinski; Sergio López-Manzaneda; Collin Hill; María Del Mar Mañu-Pereira; Miguel A Martín; Israel Orman; Joan-LLuis Vives-Corrons; Charles Kung; Axel Schambach; Shengfang Jin; Juan A Bueren; Eugenio Montini; Susana Navarro; Jose C Segovia
Journal:  Mol Ther       Date:  2016-05-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.